-
Nature Biotechnology3 weeks ago
Generalist biological artificial intelligence in modeling the language of life
Nature Biotechnology, Published online: 20 March 2026; doi:10.1038/s41587-026-03064-w This Review discusses the promises and pitfalls of biological AI algorithms and presents a vision for generalist biological...
-
Nature Biotechnology3 weeks ago
Functional integration of an autologous engineered esophagus in a large-animal model
Nature Biotechnology, Published online: 20 March 2026; doi:10.1038/s41587-026-03043-1 A tissue-engineered esophageal segment is functional in minipigs.
-
AI & Machine Learning in Biotechnology3 weeks agoDrug development is booming in China. Should the U.S. view it as a threat or an opportunity?
If the U.S. wants to hold on to its title as the world’s top biotech innovator, it might want to take a page out of China’s...
-
AI & Machine Learning in Biotechnology3 weeks agoIndependent autism committee kicks off efforts to counter RFK Jr., influence Congress
WASHINGTON — Autism scientists and advocates met Thursday to develop an agenda for autism research, the first gathering of a group that hopes to command the...
-
AI & Machine Learning in Biotechnology3 weeks agoSTAT+: Trump’s Medicare director seeks to rein in expectations for TrumpRx
Chris Klomp, a top official at the federal health department, offered a reality check on President Trump’s drug discount platform, TrumpRx, while speaking at a STAT...
-
Endpoints News3 weeks ago
Tech talent comes to healthcare
In San Francisco a few weeks ago, I caught up with Nworah Ayogu, partner at Thrive Capital. Thrive had recently announced that it raised a $10...
-
GEN – Genetic Engineering & Biotechnology News3 weeks agoCommercializing Autologous Cell Therapy: Bridging Clinical and Large-Scale Manufacturing
Register Now Panelists: Pascal Touchon Operating Partner, Jeito CapitalChair & Member of Board of Directors, Advisor, RoslinCT View Bio Panelist Pascal Touchon Pascal Touchon serves as...
-
GEN – Genetic Engineering & Biotechnology News3 weeks ago
Baylor College of Medicine Taps Nautilus’ Voyager for Cancer Proteomics
Nautilus Biotechnology has announced Baylor College of Medicine as the first customer of the early access program for its proteomics technology. As part of the program,...
-
GEN – Genetic Engineering & Biotechnology News3 weeks agoNovel Schizophrenia Biomarker and Potential Therapeutic Strategy Identified
Current schizophrenia (SZ) medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms, such as disorganized thinking or executive dysfunction. As a...
-
Uncategorized3 weeks ago
Novo’s High Dose Wegovy Scores FDA Priority Voucher Program’s 4th Nod
With the approval of Wegovy HD, Novo Nordisk joins Johnson & Johnson, Boehringer Ingelheim and USAntibiotics as beneficiaries of the FDA’s Commissioner’s National Priority Voucher program,...
Gilead Swallows Another Partner, Paying up to $5B for ADC Specialist Tubulis
